| LEADER | 05663cam a2200625Ii 4500 | ||
|---|---|---|---|
| 001 | mig00005471548 | ||
| 006 | m o d | ||
| 007 | cr cnu---unuuu | ||
| 008 | 160831s2017 nyu of 001 0 eng d | ||
| 005 | 20220721163758.6 | ||
| 035 | 0 | 0 | |a ocm00000001wrldshrocn957558066 |
| 035 | |a 1WRLDSHRocn957558066 | ||
| 040 | |a N$T |b eng |e rda |e pn |c N$T |d IDEBK |d N$T |d YDX |d OCLCF |d TEFOD |d OCLCO |d OCLCQ |d OCLCA |d AGLDB |d SNK |d DKU |d AUW |d INTCL |d MHW |d BTN |d IGB |d D6H |d VTS |d AU@ |d OCLCO |d G3B |d OCLCO |d OCLCA |d S8J |d S9I |d STF |d GWM |d OCLCO | ||
| 019 | |a 960999940 |a 961202198 | ||
| 020 | |a 9780826166678 |q (electronic bk.) | ||
| 020 | |a 0826166679 |q (electronic bk.) | ||
| 020 | |z 9780826166661 | ||
| 020 | |z 0826166660 | ||
| 035 | |a (OCoLC)957558066 |z (OCoLC)960999940 |z (OCoLC)961202198 | ||
| 037 | |a 25FBAAB6-E27D-4513-BDA5-1E3FBBBE1945 |b OverDrive, Inc. |n http://www.overdrive.com | ||
| 050 | 4 | |a RM301 | |
| 060 | 1 | 4 | |a WY 49 |
| 082 | 0 | 4 | |a 615.1 |2 23 |
| 049 | |a TXMM | ||
| 100 | 1 | |a Wirfs, Mari J., |e author. | |
| 245 | 1 | 4 | |a The APRN's complete guide to prescribing drug therapy 2017 / |c Mari J. Wirfs. |
| 264 | 1 | |a New York, NY : |b Springer Publishing Company, LLC, |c [2017] | |
| 300 | |a 1 online resource (pages) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 347 | |a data file |2 rda | ||
| 500 | |a Includes index. | ||
| 588 | 0 | |a Online resource; title from PDF title page (EBSCO, viewed September 12, 2016). | |
| 505 | 0 | |a Cover; Title; Copyright; Contents; Reviewers; Abbreviations; Preface; Acknowledgments; Share The APRN's Complete Guide to Prescribing Drug Therapy 2017; Section I: Drug Therapy by Clinical Diagnosis; Acetaminophen Overdose; Antidote/Chelating Agent; Acne Rosacea; Topical Alpha-2 Agonist; Topical Antimicrobials; Oral Antimicrobials; Acne Vulgaris; Antibacterial Soaps; Topical Antimicrobials; Oral Antimicrobials; Topical Retinoids; Topical Retinoid/Antimicrobial Combinations; Oral Retinoid; Oral Contraceptives; Acromegaly; Growth Hormone Receptor Antagonist; Actinic Keratosis | |
| 505 | 8 | |a Alcohol Dependence/Alcohol Withdrawal SyndromeAlcohol Withdrawal Syndrome; Abstinence Therapy; Aversion Therapy; Allergic Reaction: General; Parenteral Antihistamine; Alzheimer's Disease; Nutritional Supplement; Reversible Anticholinesterase Inhibitors (RAIs); N-Methyl-D-Aspartate (NMDA) Receptor Antagonist; N-Methyl-D-Aspartate (NMDA) Receptor Antagonist/Acetylcholin-Esterase Inhibitor Combination; Ergot Alkaloid (Dopamine Agonist); Amebiasis; Amebiasis (Intestinal); Amebiasis (Extraintestinal); Amebic Liver Abscess; Anti-Infectives; Amenorrhea: Secondary; Anaphylaxis | |
| 505 | 8 | |a Anaphylaxis Emergency Treatment KitsAnemia of Chronic Kidney Disease (CKD) and Chronic Renal Failure (CRF); Erythropoiesis Stimulating Agents (ESAs); Erythropoietin Human, Recombinant; Anemia: Folic Acid Deficiency; Anemia: Iron Deficiency; Iron Preparations; Anemia: Megaloblastic/Anemia: Pernicious; Angina Pectoris: Stable; Calcium Antagonists; Beta-Blockers; Nitrates; Non-Nitrate Peripheral Vasodilator; Nitrate/Peripheral Vasodilator Combination; Non-Nitrate Anti-Anginal; Anorexia/Cachexia; Appetite Stimulants; Anthrax (Bacillus Anthracis) | |
| 505 | 8 | |a Postexposure Prophylaxis of Inhalational Anthrax and Treatment of Inhaled and Cutaneous Anthrax InfectionImmune Globulin; Treatment of Inhalational, GI, and Oropharyngeal Anthrax; Anxiety Disorder: Generalized (GAD)/Anxiety Disorder: Social (SAD); 1st Generation Antihistamine; Azaspirones; Benzodiazepines; Tricyclic Antidepressants (TCAs); Phenothiazines; Selective Serotonin Reuptake Inhibitors (SSRIs); Serotonin and Norepinephrine Reuptake Inhibitors (SNRIs); Combination Agents; Aphthous Stomatitis (Mouth Ulcer, Canker Sore); Anti-Inflammatory Agents; Topical Anesthetics | |
| 505 | 8 | |a Debriding Agent/CleanserAnti-Infectives; Aspergillosis (Scedosporium Apiospermum, Fusarium SPP.); Invasive Infection; Asthma; Leukotriene Receptor Antagonists (LRAs); IGE Blocker (IGG1K Monoclonal Antibody); Inhaled Anticholinergics; Inhaled Corticosteroids; Inhaled Mast Cell Stabilizers (Prophylaxis); Inhaled Beta Agonists (Bronchodilators); Inhaled Racepinephrine (Bronchodilator); Inhaled Long-Acting Anticholinergic; Inhaled Anticholinergic/Beta Agonist; Inhaled Beta Agonist (Long-Acting) (LABA); Corticosteroid/Inhaled Long-Acting Beta Agonist (LABA); Oral Beta2-Agonists (Bronchodilators) | |
| 590 | |a EBSCO eBook Clinical Collection | ||
| 590 | |a EBSCO eBook Academic Comprehensive Collection North America | ||
| 650 | 0 | |a Drugs |v Handbooks, manuals, etc. | |
| 655 | 2 | |a Handbook | |
| 655 | 7 | |a Handbooks and manuals. |2 fast |0 (OCoLC)fst01423877 | |
| 655 | 7 | |a Handbooks and manuals. |2 lcgft | |
| 655 | 7 | |a Guides et manuels. |2 rvmgf | |
| 730 | 0 | |a WORLDSHARE SUB RECORDS | |
| 776 | 0 | 8 | |i Print version: |a Wirfs, Mari J. |t APRN's complete guide to prescribing drug therapy 2017. |d New York, NY : Springer Publishing Company, LLC, [2017] |z 9780826166661 |w (DLC) 2016013691 |w (OCoLC)945566006 |
| 856 | 4 | 0 | |u https://ezproxy.mtsu.edu/login?url=https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=1343276 |z CONNECT |3 eBooks on EBSCOhost |t 0 |
| 949 | |a ho0 | ||
| 994 | |a 92 |b TXM | ||
| 998 | |a wi |d z | ||
| 999 | f | f | |s 71f44891-cab4-4456-92c1-9208c0de26e0 |i dd1454db-e626-4cc1-adbc-1c4096d702dc |t 0 |
| 952 | f | f | |a Middle Tennessee State University |b Main |c James E. Walker Library |d Electronic Resources |t 1 |e RM301 |h Library of Congress classification |
| 856 | 4 | 0 | |3 eBooks on EBSCOhost |t 0 |u https://ezproxy.mtsu.edu/login?url=https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=1343276 |z CONNECT |
